Accrued Liabilities, Current in USD of AXIM BIOTECHNOLOGIES, INC. from Q4 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Axim Biotechnologies, Inc. quarterly Accrued Liabilities, Current history and change rate from Q4 2020 to Q3 2023.
  • Axim Biotechnologies, Inc. Accrued Liabilities, Current for the quarter ending 30 Sep 2023 was $0.000.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $0 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 $0 $0 30 Jun 2023 10-Q 21 Aug 2023
Q1 2023 $0 -$1.96K -100% 31 Mar 2023 10-Q 22 May 2023
Q4 2022 $0 -$1.7K -100% 31 Dec 2022 10-K 16 Apr 2024
Q2 2022 $0 -$1.19K -100% 30 Jun 2022 10-Q 16 Aug 2022
Q1 2022 $1.96K 31 Mar 2022 10-Q 23 May 2022
Q4 2021 $1.7K +$1.03K +152% 31 Dec 2021 10-K 16 Apr 2024
Q3 2021 $1.45K 30 Sep 2021 10-Q 22 Nov 2021
Q2 2021 $1.19K 30 Jun 2021 10-Q 23 Aug 2021
Q4 2020 $675 31 Dec 2020 10-K/A 19 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.